ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 on the Additional Practice-Informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study: Adagrasib in KRASG12Cm NSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Jun Zhang
By
ESMO 2022 Conference Coverage
FEATURING
Jun Zhang
272 views
September 27, 2022
This video was recorded prior to the FDA granting approval to Adagrasib (Krazati) on December ...
read more ↘ 12, 2022
↖ read less
read more ↘ 12, 2022
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung